Cheng Yong-Chong, Li Yang, Xu Chang-Tai, Xu Li-Xian, Pan Bo-Rong
Department of Anesthesiology, the Third Hospital of Chinese PLA, Baoji 721004, Shaanxi Province, China.
Int J Ophthalmol. 2011;4(2):170-4. doi: 10.3980/j.issn.2222-3959.2011.02.12. Epub 2011 Apr 18.
To compare the effect of propofol versus urapidil on hemodynamics and intraocular pressure during anesthesia and extubation for ophthalmic patients.
Eighty-two surgical patients (Class: ASA I-II) were randomly assigned to propofol (n=41) and urapidil groups (n=41). Their gender, age, body mass, operation time and dosage of anesthetics had no significant difference between the two groups (P>0.05). The patients of propofol and urapidil groups were given propofol (1.5mg/kg) and urapidil (2.5mg/kg) respectively; and two drugs were all diluted with normal saline to 8mL. Then the drugs were given to patients by slow intravenous injection. After treatment, the patients were conducted immediate suction, tracheal extubation, and then patients wore oxygen masks for 10 minutes. By double-blind methods, before the induction medication, at the suction, and 5, 10 minutes after the extubation, we recorded the systolic and diastolic blood pressure (BP), heart rate (HR), pH, PaO(2), PaCO(2), SaO(2) and intraocular pressure (IOP) respectively. The complete recovery time of the patients with restlessness (on the command they could open eyes and shaking hands) was also recorded during the extubation. The data were analyzed by using a professional SPSS 15.0 statistical software.
The incidence of cough, restlessness and glossocoma was significantly lower in the propofol group than that in the urapidil group after extubation (P<0.05). There were no episodes of hypotension, laryngospasm, or severe respiratory depression. There was no statistical difference in recovery time between two groups (P>0.05). In propofol group, the BP and HR during extubation and thereafter had no significant difference compared with those before induction, while they were significantly lower than those before giving propofol (P<0.05), and had significant difference compared with those in urapidil group (P<0.05). Compared to preinduction, the BP of urapidil group showed no obvious increase during aspiration and extubation. The HR of urapidil group had little changes after being given urapidil, and it was obviously increased compared with that before induction. The stimulation of aspiration and extubation caused less cough and agitation in propofol group than that in urapidil group (P<0.05). The IOP of propofol group showed no obvious increase during extubation compared with that in preinduction, while in the urpidil group, extubation caused IOP significantly increased (P<0.05). The changes in these indicators between the two groups had no significant difference (P>0.05).
Compared to urapidil, propofol is superior for preventing the cardiovascular and stress responses and IOP increases during emergence and extubation for the ophthalmic patients. Moreover, it has no effects on patient's recovery.
比较丙泊酚与乌拉地尔在眼科患者麻醉及拔管期间对血流动力学和眼压的影响。
82例外科手术患者(ASA分级:I-II级)随机分为丙泊酚组(n=41)和乌拉地尔组(n=41)。两组患者的性别、年龄、体重、手术时间及麻醉用药剂量无显著差异(P>0.05)。丙泊酚组和乌拉地尔组患者分别给予丙泊酚(1.5mg/kg)和乌拉地尔(2.5mg/kg);两种药物均用生理盐水稀释至8mL。然后通过缓慢静脉注射给药。治疗后,对患者立即进行吸痰、气管拔管,然后患者佩戴氧气面罩10分钟。采用双盲法,在诱导用药前、吸痰时以及拔管后5、10分钟,分别记录收缩压和舒张压(BP)、心率(HR)、pH、PaO₂、PaCO₂、SaO₂和眼压(IOP)。在拔管期间还记录了患者出现躁动(能按指令睁眼和握手)的完全恢复时间。数据采用专业的SPSS 15.0统计软件进行分析。
拔管后丙泊酚组咳嗽、躁动和舌后坠的发生率显著低于乌拉地尔组(P<0.05)。未发生低血压、喉痉挛或严重呼吸抑制事件。两组恢复时间无统计学差异(P>0.05)。丙泊酚组拔管期间及之后的血压和心率与诱导前相比无显著差异,但显著低于给予丙泊酚前(P<0.05),与乌拉地尔组相比有显著差异(P<0.05)。与诱导前相比,乌拉地尔组在吸痰和拔管期间血压无明显升高。乌拉地尔组给药后心率变化不大,但与诱导前相比明显升高。丙泊酚组吸痰和拔管刺激引起的咳嗽和躁动少于乌拉地尔组(P<0.05)。丙泊酚组拔管期间眼压与诱导前相比无明显升高,而乌拉地尔组拔管导致眼压显著升高(P<0.05)。两组这些指标的变化无显著差异(P>0.05)。
与乌拉地尔相比,丙泊酚在预防眼科患者苏醒和拔管期间的心血管及应激反应以及眼压升高方面更具优势。此外,它对患者的恢复无影响。